The SISCO Study is a four-year research project evaluating supervised inhalation services within SCS/OPS settings. In 2025, smoking was associated with ~65% of drug toxicity deaths in BC, and in response there has been a scale up of smoking-specific harm reduction sites and services in some regions. There is, however, very little scientific information regarding the use and impact of these sites. Because of this, SISCO was designed to address this critical evidence gap by accessing the acceptability, use, and health impacts of supervised inhalation sites, while prioritizing the experiences and needs of clients.

Academic and non-academic outputs from the study will allow us to better understand and demonstrate the impact of these sites. It will also help to inform how these services can be improved and expanded, in order to better respond to the unregulated drug poisoning crisis. With strong involvement from key partners, this project has the potential to shape more inclusive, responsive, and life-saving health services across Canada.